when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,499 stories

May 15, 26FDA Approves Adjuvant Atezolizumab for MRD+ Muscle-Invasive Bladder Canceronclive

May 15, 26Detalimogene Voraplasmid Yields 54% CR Rate in Heavily Pretreated BCG-Unresponsive NMIBC With CISonclive

May 15, 26Roswell Park Team Members Take Part in Global Conference Dedicated to Indigenous Peoples and Canceronclive

May 15, 26Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersbiopharma dive

May 15, 26Candel reports prostate cancer drug's long-term data ahead of FDA filingendpoints

May 15, 26Poll Findings Highlight the Most Anticipated GU Cancer Abstracts at ASCO 2026onclive

May 15, 26Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placestat

May 15, 26OncLive Polls Reveal Picks for Top GI Cancer Abstracts, Areas of Interest at ASCO 2026onclive

May 15, 26STAT+: Top U.S. officials pressured Germany to pay more for prescription drugsstat

May 15, 26PSA screening for prostate cancer reduces disease-specific deaths, new review showsstat

May 14, 26Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Preventiononclive

May 14, 26Makary’s departure and Cassidy’s tenuous Senate seatstat

May 14, 26IO in NMIBC, Radioligand Therapy in mHSPC Highlight Key Presentations to Watch at AUA 2026onclive

May 14, 26Imaging Clues That Raise Suspicion for Diffuse Midline Gliomaonclive

May 14, 26Perioperative Durvalumab Plus Neoadjuvant EV Displays EFS, OS Benefits vs SOC in MIBConclive

May 14, 26Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian Canceronclive

May 14, 26Create Medicines raises $122M to bolster in vivo CAR-T therapiesbiopharma dive

May 14, 26Dana-Farber Study Finds Stage IV Breast Cancer Increasing in Incidence and Proportion Over the Last Decadeonclive

May 14, 26REVELUTION-2 Trial Is Evaluating Cardiovascular Risk With Relugolix Plus Abiraterone Acetate in High-Risk Prostate Canceronclive

May 14, 26AstraZeneca follows Merck with Phase 3 win in bladder cancerendpoints

May 14, 26STAT+: BeOne wins FDA approval in lymphoma racestat

May 14, 26Case Introduction and ctDNA as Emerging Risk Factoronclive

May 14, 26ASCO 2026: All Eyes Are on Daraxonrasib and a Wave of Novel Targeted Therapies in GI Malignanciesonclive

May 14, 26MET Alterations in NSCLC: Amplification, Mutations, and Therapeutic Strategiesonclive

May 14, 26Planned HERIZON-GEA-01 Analyses and the Doublet-vs-Triplet Questiononclive

May 14, 26HERIZON-GEA-01 Efficacy Results and Interpretation of Duration of Responseonclive

May 14, 26Five-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial (CT029)onclive

May 14, 26Emerging Biomarkers in NSCLC: TROP2 Scoring and MTAP Lossonclive

May 14, 26STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage studystat

May 14, 26STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionstat

← prevpage 42 of 50next →